Dynamic analysis of MR-PET data on brain tumors
© Morgado et al; licensee Springer 2014
Published: 29 July 2014
The introduction of hybrid MR-PET scanners offers new perspectives to better correlate MR and PET data with respect to time and space domain. In case of brain tumor patients, dynamic susceptibility contrast (DSC)-MRI is often used to measure perfusion levels of brain, while dynamic [18F]-fluoro-ethyl-tyrosine (FET)-PET provides additional functional information.
The dynamic analysis of data is becoming more relevant, rather than static analysis, and with this the extraction of parametric images. In this context, the aim of this work is to compare dynamic MR-PET data based on different features.
A FET-PET scan was carried out on the 3T-MR-BrainPET  on each patient. Data was acquired for 60 min after injection in list-mode and reconstructed using OSEM3D software (4 subsets, 32 iterations). All MRI sequences were acquired simultaneous to the PET measurement. In this work, MPRAGE and DSC-MRI based on an EPI sequence images are used.
For the dynamic analysis, data was co-registered and the same parameters were extracted, with Matlab, from MR-PET data to produce peak, time to peak (TTP), area under the curve (AUC) and wash-in parametric images.
In FET-PET parametric images an uptake area can be identified in the region of morphological changes in anatomical MR. The parametric images provide extra information in addition to the summed FET-PET images.
The extracted parametric images from dynamic MR-PET showed good spatial and temporal agreement (Figure 1). These results suggest that dynamic MR-PET may have extra information about biology and that the combination of simultaneous acquisition and analysis may be beneficial.
- Herzog H, Langen K-J, Weirich C, et al.: High resolution BrainPET combined with simultaneous MRI. Nuklearmedizin. Nuclear Medicine 2011,50(2):74–82. 10.3413/Nukmed-0347-10-09PubMedView ArticleGoogle Scholar
- Paulson ES, Schmainda KM: Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors. Radiology 2008,249(2):601–613. 10.1148/radiol.2492071659PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.